Talk to Sam

(866) 682 9815

Search inside this page

All regions

Free Market Research Guides to Download

Biotechnology Market Statistics, May 2013

You might be interested in: protein, stem cell, genetic, more »

» Read Business News

1-30 of about 28 000 news
Vaccine Innovation in Canada and Pakistan: UVAS faculty member wins research grant from Canada to develop vaccine against toxoplasma disease

Vaccine Innovation In Canada And Pakistan: Uvas Faculty Member Wins Research Grant From Canada To Develop Vaccine Against Toxoplasma Disease

  • Industry news
  • 8 hours ago
  • by HT Media

LAHORE , 2013-05-26 -- Dr Muhammad Imran Rashid , an Assistant Professor of the University of Veterinary , Animal Sciences Lahore, has won a Rs 10.925 million grant from "Grand Challenges Canada", a funding agency of Canada , for his research project titled "Development of toxoplasma multiprotein sub-unit vaccine , their experiment trials in mouse model administered intranasally with t...

  • Industries : Biopharmaceutical
  • Countries : Canada, Pakistan
Vaccine Trends in Canada: UVAS faculty member wins research grant from Canada to develop vaccine against toxoplasma disease

Vaccine Trends In Canada: Uvas Faculty Member Wins Research Grant From Canada To Develop Vaccine Against Toxoplasma Disease

  • Industry news
  • 23 hours ago
  • by Plus Media Solutions Pakistan

LAHORE : Dr Muhammad Imran Rashid , an Assistant Professor of the University of Veterinary , Animal Sciences Lahore, has won a Rs 10.925 million grant from ?Grand Challenges Canada?, a funding agency of Canada , for his research project titled ?Development of toxoplasma multiprotein sub-unit vaccine , their experiment trials in mouse model administered intranasally with tr...

  • Industries : Biopharmaceutical
  • Countries : Canada
Genomics Technology Trends in The United States: Cellectis Gets 2 Patents for TAL-effector nuclease

Genomics Technology Trends In The United States: Cellectis Gets 2 Patents For Tal-effector Nuclease

  • Industry news
  • 1 day ago
  • by ProQuest Information & Learning

Cellectis , a global genome engineering specialist, announced the issuance by the USPTO on May 14-th , of 2 new US patents (US 8,440,431 , US 8,440,432) directed to TAL-effector nucleases. As a Industry player focusing in the genome engineering Market, the molecules produced by Cellectis have been distributed to laboratories over the world under the trademark TALEN. The technology provides t...

  • Industries : Genomics
  • Countries : United States
Genomics Technology Trends in The United States: Callida Genomics Assigned Patent for Single Molecule Arrays for Genetic and Chemical Analysis

Genomics Technology Trends In The United States: Callida Genomics Assigned Patent For Single Molecule Arrays For Genetic And Chemical Analysis

  • Industry news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- Callida Genomics, Sunnyvale, Calif. , has been assigned a patent (8,445,196) developed by 5 Company-inventors for a "single molecule arrays for genetic , chemical analysis." The Company-inventors are Radoje T. Drmanac , Los Altos Hills, Calif. , Matthew J. Callow , Redwood City, Calif. , Snezana Drmanac , Los Altos Hills, Calif. , B...

  • Industries : Genomics
  • Countries : United States
Biological Therapy Technology Trends in The United States: Johns Hopkins University Assigned Patent

Biological Therapy Technology Trends In The United States: Johns Hopkins University Assigned Patent

  • Industry news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- Johns Hopkins University , Baltimore , has been assigned a patent (8,445,447) developed by Lieping Chen , New Haven, Conn. , for "B7-DC variants immunogenic compositions , methods of use thereof." The abstract of the patent published by the U.S. Patent , Trademark Office states: "Compositions , methods for costimulating T c...

  • Industries : Biological Therapy
  • Countries : United States
Genomics Innovation Trends in The United States: Illumina Assigned Patent

Genomics Innovation Trends In The United States: Illumina Assigned Patent

  • Company news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- Illumina , San Diego , has been assigned a patent (8,445,412) developed by Bernard Hirschbein , Hayward, Calif. , , Filiz Gorpe-Yasar , Hayward, Calif. , for a "separation of pyrophosphate release , pyrophosphate detection." The abstract of th...

  • Industries : Genomics
  • Countries : United States
Genome Sequencing and Genetic Code Innovation Trends in The United States: Scripps Research Institute Assigned Patent

Genome Sequencing And Genetic Code Innovation Trends In The United States: Scripps Research Institute Assigned Patent

  • Company news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- Scripps Research Institute , La Jolla, Calif. , has been assigned a patent (8,445,446) developed by 5 Company-inventors for "unnatural reactive amino acid genetic code additions." The Company-inventors are Alexander Deiters , La Jolla, Calif. , Ashton T. Cropp , Bethesda, Md. , Jason W. Chin , Cambridge, United Kingdom , Christopher ...

  • Industries : Genomics
  • Countries : United States
Biosensor Innovation in The United States: Bayer HealthCare Assigned Patent for Temperature-adjusted Analyte Determination for Biosensor Systems

Biosensor Innovation In The United States: Bayer Healthcare Assigned Patent For Temperature-adjusted Analyte Determination For Biosensor Systems

  • Industry news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- Bayer HealthCare , Tarrytown, N.Y. , has been assigned a patent (8,445,290) developed by Huan-Ping Wu , Granger, Ind. , , Christine D. Nelson , Edwardsburg, Mich. , for a "temperature-adjusted analyte determination for biosensor systems." The abstract of the patent published by the U.S. Patent , Trademark Office state...

  • Industries : Biotechnology
  • Countries : United States
Stem Cell Technology Trends in The United States, Netherlands and Japan: Stanford University Assigned Patent

Stem Cell Technology Trends In The United States, Netherlands And Japan: Stanford University Assigned Patent

  • Industry news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- Stanford University , Palo Alto, Calif. , has been assigned a patent (8,445,281) developed by Kazuhiro Kawamura , Akita, Japan , Aaron J.W. Hsueh , Stanford, Calif. , , Sabine M. Mulders , Oss, The Netherlands , for "in vitro exposure of immature oocytes to BDNF enhances generation of embryonic stem cells." The abstract of ...

  • Industries : Biological Therapy
  • Countries : United States, Netherlands, Japan
Biopharmaceutical Innovation Trends in The United States: Merck Sharp & Dohme Assigned Patent

Biopharmaceutical Innovation Trends In The United States: Merck Sharp & Dohme Assigned Patent

  • Company news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- Merck Sharp & Dohme, Rahway, N.J. , has been assigned a patent (8,445,227) developed by 7 Company-inventors for "N-acetylglucosaminyltransferase III expression in lower eukaryotes." The Company-inventors are Piotr Bobrowicz , Hanover, N.H. , Stephen R. Hamilton , Enfield, N.H. , Tillman U. Gerngross , Hanover, N.H. , Stefan Wildt , ...

  • Industries : Biopharmaceutical
  • Countries : United States
Transgenic Plant Innovation in The United States: University of Kentucky Assigned Patent

Transgenic Plant Innovation In The United States: University Of Kentucky Assigned Patent

  • Industry news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- The University of Kentucky, Lexington , Ky., has been assigned a patent (8,445,231) developed by Joseph Chappell , Lexington, Ky. , , Lyle F. Ralston , Chesterfield, Mo. , for "cytochrome P450s , uses thereof." The abstract of the patent published by the U.S. Patent , Trademark Office stat...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : United States
Genomics Technology Trends in The United States: Research Development Foundation Assigned Patent

Genomics Technology Trends In The United States: Research Development Foundation Assigned Patent

  • Industry news
  • 1 day ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-25 -- Research Development Foundation , Carson City, Nev. , has been assigned a patent (8,445,425) developed by 6 Company-inventors for an "urocortin-III , uses thereof." The Company-inventors are Wylie W. Vale Jr ., La Jolla, Calif. , Kathy A. Lewis , San Diego , Marilyn H. Perrin , La Jolla, Calif. , Koichi S. Kunitake , San Diego , an...

  • Industries : Genomics
  • Countries : United States
Antibody Innovation Trends in Japan: U.S. Patent granted to Tao Health Life Pharma on 2013-05-21 for

Antibody Innovation Trends In Japan: U.s. Patent Granted To Tao Health Life Pharma On 2013-05-21 For "antibody And Use Thereof" (japanese Inventors)

  • Company news
  • 1 day ago
  • by HT Media

ALEXANDRIA, Va. , 2013-05-25 -- United States Patent no. 8,445,649, issued on May 21 , was assigned to Tao Health Life Pharma Company Ltd. ( Kyoto, Japan ). "Antibody , use thereof" was invented by Minako Hoshi ( Kyoto, Japan ), Michio Sato ( Tokyo ), Shoji Ideno ( Osaka, Japan ), Koji Naito ( Osaka, Japan ), Satoshi Horie ( Osaka, Japan ), Munehiro Noda ( Osaka, Japan ) , Haji...

  • Industries : Biopharmaceutical
  • Countries : Japan
Biomedical Technology Trends in The United States: California Biomedical Sector Leaders Urge Congress to Take Action on FDA User Fees for FY2014

Biomedical Technology Trends In The United States: California Biomedical Sector Leaders Urge Congress To Take Action On Fda User Fees For Fy2014

  • Industry news
  • 1 day ago
  • by PR Web

( LA JOLLA, Calif. ) (PRWEB) 2013-05-24 CHI-California Healthcare Institute today submitted a letter to House Appropriators , the California congressional delegation, joined by over 40 biomedical companies, urging them to restore sequestered Market user fees paid to the U.S. Food , Drug Administration in 2013, , to ensure that future across-the-board cuts will not include us...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical Production Statistics in The United States: Sente, incorporated Appoints Distinguished Sector Veteran, Magda Marquet, Ph.D. to Its Board of Directors

Biopharmaceutical Production Statistics In The United States: Sente, Incorporated Appoints Distinguished Sector Veteran, Magda Marquet, Ph.d. To Its Board Of Directors

  • Company news
  • 1 day ago
  • by GlobeNewswire

SAN DIEGO , 2013-05-24 (GLOBE NEWSWIRE) -- Sente, incorporated , a privately held cosmeceutical Industry player engaged in the development of differentiated medical skincare products based on glycoproteins, announced today that it has appointed Magda Marquet , Ph.D. to its board of directors, effective immediately. Dr. Marquet is Sente's 4th director , brings additional biotechnology Market operat...

  • Industries : Biopharmaceutical
  • Countries : United States
Stem Cell Innovation Trends in The United States: Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles

Stem Cell Innovation Trends In The United States: Icahn School Of Medicine At Mount Sinai Grants Exclusive License To Cellular Dynamics International For Development Of A Cellular Therapy For Cardiac Muscles

  • Company news
  • 1 day ago
  • by PR Web

New York, NY (PRWEB) 2013-05-24 The Icahn School of Medicine at Mount Sinai has granted Cellular Dynamics International (CDI) exclusive license rights to commercially develop cardiomyocyte progenitors for in vivo cell therapy , regenerative medicine applications. These cells are capable of further differentiation into the multiple cell types of the heart, including cardiomyocytes...

  • Industries : Biological Therapy
  • Countries : United States
Bioprocessing Innovation Trends in Singapore: Agilent Technologies, University of Rouen and A*STAR's Bioprocessing Technology Institute to Further Innovation in Biopharmaceuticals and Glycomics

Bioprocessing Innovation Trends In Singapore: Agilent Technologies, University Of Rouen And A*star's Bioprocessing Technology Institute To Further Innovation In Biopharmaceuticals And Glycomics

  • Company news
  • 2 days ago
  • by M2 Communications

ENP Newswire - 24 May 2013 Release date- 23052013 - Agilent Technologies incorporated (NYSE: A), the Glyco-MEV laboratory at the University of Rouen , in France , , the Bioprocessing Technology Institute at the Agency for Science , Technology , Research (A*STAR), in Singapore , have signed a memorandum of understanding to work together in order to develop tools to effectively analyze bi...

  • Industries : Biopharmaceutical
  • Countries : Singapore
Biopharmaceutical Key Players in Europe: AFTOVAXPUR DOE, 1-3 inactivated, purified FMD virus(es) out of a set of 7 (multistrain). Opinion date: 16-May-2013.

Biopharmaceutical Key Players In Europe: Aftovaxpur Doe, 1-3 Inactivated, Purified Fmd Virus(es) Out Of A Set Of 7 (multistrain). Opinion Date: 16-may-2013.

  • Industry news
  • 2 days ago
  • by Elsevier CBNB

On 16 May 2013 , the Committee for Medicinal Products for Veterinary Use (CVMP) adopted a positive opinion2 , recommending the granting of a marketing authorisation for the veterinary medicinal product AFTOVAXPUR DOE, emulsion for injection. The product is intended for active immunisation of cattle , sheep from 2 months of age , pigs from 10 weeks of age against foot-,-mouth disease (FMD)...

  • Industries : Biopharmaceutical
  • Countries : Europe
Industrial Biotechnology Innovation Trends: Verenium reports net loss for First quarter

Industrial Biotechnology Innovation Trends: Verenium Reports Net Loss For First Quarter

  • Company news
  • 2 days ago
  • by Datamonitor

Verenium Corporation , an industrial biotechnology Industry player, has reported that net loss attributable to the Industry player for the Q1 ended 2013-03-31 was US Dollars 6.06 million , or US Dollars 0.47 loss per diluted share, compared to a net incomIndustry playerbutable to the company of US Dollars 29.30 million or US Dollars 2.26 per diluted share...

  • Industries : Biotechnology
Molecular Biology Technology Trends: Queen's humble arrival

Molecular Biology Technology Trends: Queen's Humble Arrival

  • Industry news
  • 2 days ago
  • by Telegraph Group

The Queen swapped her Bentley for a bus yesterday as she visited a research institute known as "the Nobel Prize factory". Rather than arriving in an official state automobile, the monarch , the Duke of Edinburgh caught a scheduled train service from London to Cambridge , before hopping on a bus for the short journey to the Medical Research Council Laboratory of Molecular Biology . The visi...

  • Industries : Genomics
Synthetic Biology Innovation Trends in Japan: World Intellectual Property Organization PUBLISHES PATENT OF ASAHI KASEI CHEMICALS FOR

Synthetic Biology Innovation Trends In Japan: World Intellectual Property Organization Publishes Patent Of Asahi Kasei Chemicals For "method For Producing Myo-inositol And Myo-inositol Derivative" (japanese Inventors)

  • Company news
  • 2 days ago
  • by HT Media

GENEVA , 2013-05-24 -- Publication No. WO/2013/073483 was published on May 23 . Title of the invention: "METHOD FOR PRODUCING MYO-INOSITOL , MYO-INOSITOL DERIVATIVE." Applicants: ASAHI KASEI CHEMICALS CORPORATION (JP). Inventors: Kazunobu Konishi (JP), Shinichi Imazu (JP) , Mayumi Sato (JP). as reported by the abstract* posted by the World Intellectual Property O...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : Japan
Biopharmaceutical Technology Trends in The United States: World Intellectual Property Organization PUBLISHES PATENT OF UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION FOR

Biopharmaceutical Technology Trends In The United States: World Intellectual Property Organization Publishes Patent Of University Of Pittsburgh - Of The Commonwealth System Of Higher Education For "immunogenic Tumor Associated Stromal Cell...

  • Industry news
  • 2 days ago
  • by HT Media

World intellectual property organization publishes patent of university of pittsburgh - Of the commonwealth system of higher education for "immunogenic tumor associated stromal cell antigen peptides , methods of their use" (american, indian inventors) geneva , 2013-05-24 -- Publication no. Wo/2013/074820 was published on may 23 . Title of the invention: "immunogenic tumor associated stromal cell antigen peptides , metho...

  • Industries : Biopharmaceutical
  • Countries : United States
Dna Sequencing Innovation Trends in The United States: Life Technologies Assigned Patent

Dna Sequencing Innovation Trends In The United States: Life Technologies Assigned Patent

  • Company news
  • 2 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-24 -- Life Technologies , Carlsbad, Calif. , has been assigned a patent (8,445,945) developed by 4 Company-inventors for a "low noise chemically-sensitive field effect transistors." The Company-inventors are Jonathan Rothberg , Guilford, Conn. , Wolfgang Hinz , New Haven, Conn. , Kim Johnson , Carlsbad, Calif. , , James Bustillo , Castr...

  • Industries : Genomics
  • Countries : United States
Genomics Innovation Trends in The United States: Applied Biosystems Assigned Patent

Genomics Innovation Trends In The United States: Applied Biosystems Assigned Patent

  • Company news
  • 2 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-24 -- Applied Biosystems , Carlsbad, Calif. , has been assigned a patent (8,445,657) developed by 7 Company-inventors for "multiplex compositions , methods for quantification of human nuclear DNA , human male DNA , detection of PCR inhibitors." The Company-inventors are Jaiprakash Shewale , Santa Clara, Calif. , Manohar Furtado , San R...

  • Industries : Genomics
  • Countries : United States
Antibody Innovation Trends in The United States: AbbVie Biotherapeutics Assigned Patent

Antibody Innovation Trends In The United States: Abbvie Biotherapeutics Assigned Patent

  • Company news
  • 2 days ago
  • by Targeted News Service

By Targeted News Service ALEXANDRIA, Va. , 2013-05-24 -- AbbVie Biotherapeutics, Redwood City, Calif. , has been assigned a patent (8,445,646) developed by 4 Company-inventors for a "therapeutic use of anti-CS1 antibodies." The Company-inventors are Marna Williams , Palo Alto, Calif. , J. Yun Tso , Menlo Park, Calif. , Nicholas F. Landolfi , Menlo Park, Calif. , , Gao Liu , Mountain View...

  • Industries : Biopharmaceutical
  • Countries : United States
Genomics Innovation Trends in The United States: U.S. Patent granted to Research Development Foundation on 2013-05-21 for

Genomics Innovation Trends In The United States: U.s. Patent Granted To Research Development Foundation On 2013-05-21 For "urocortin-iii And Uses Thereof" (california Inventors)

  • Company news
  • 2 days ago
  • by HT Media

ALEXANDRIA, Va. , 2013-05-24 -- United States Patent no. 8,445,425, issued on May 21 , was assigned to Research Development Foundation ( Carson City, Nev. ). "Urocortin-III , uses thereof" was invented by Wylie W. Vale Jr . ( La Jolla, Calif. ), Kathy A. Lewis ( San Diego ), Marilyn H. Perrin ( La Jolla, Calif. ), Koichi S. Kunitake ( San Diego ), Jean E. Rivier ( La Jolla, Calif...

  • Industries : Genomics
  • Countries : United States
Stem Cell Technology Trends in The United States and Canada: World Intellectual Property Organization PUBLISHES PATENT OF STEMTECH INTERNATIONAL FOR

Stem Cell Technology Trends In The United States And Canada: World Intellectual Property Organization Publishes Patent Of Stemtech International For "use Of Foti To Enhance Stem Cell Mobilization And Proliferation" (american, Canadian Inventors)

  • Industry news
  • 2 days ago
  • by HT Media

GENEVA , 2013-05-24 -- Publication No. WO/2013/074801 was published on May 23 . Title of the invention: "USE OF FOTI TO ENHANCE STEM CELL MOBILIZATION , PROLIFERATION." Applicants: STEMTECH INTERNATIONAL incorporated (US). Inventors: Gitte S. Jensen (CA) , Christian Drapeau (US). as reported by the abstract* posted by the World Intellectual Property Organization : "The present invention ...

  • Industries : Biological Therapy
  • Countries : United States, Canada
Biomarker Innovation Trends in The United States: World Intellectual Property Organization PUBLISHES PATENT OF MEMORIAL SLOAN-KETTERING CANCER CENTER FOR

Biomarker Innovation Trends In The United States: World Intellectual Property Organization Publishes Patent Of Memorial Sloan-kettering Cancer Center For "2-hydroxyglutarate As A Biomarker For Chronic Hypoxia" (american Inventors)

  • Company news
  • 2 days ago
  • by HT Media

GENEVA , 2013-05-24 -- Publication No. WO/2013/075065 was published on May 23 . Title of the invention: "2-HYDROXYGLUTARATE AS A BIOMARKER FOR CHRONIC HYPOXIA." Applicants: MEMORIAL SLOAN-KETTERING CANCER CENTER (US). Inventors: David R. Wise (US), Patrick S. Ward (US) , Craig B. Thompson (US). as reported by the abstract* posted by the World Intellectual Property Organization ...

  • Industries : Genomics
  • Countries : United States
Antibody Innovation Trends in The United States: World Intellectual Property Organization PUBLISHES PATENT OF AMGEN, KEVIN J. HAMBLETT AND JOHN STEPHEN HILL FOR

Antibody Innovation Trends In The United States: World Intellectual Property Organization Publishes Patent Of Amgen, Kevin J. Hamblett And John Stephen Hill For "methods Of Treating Epidermal Growth Factor Deletion Mutant Viii Related...

  • Company news
  • 2 days ago
  • by HT Media

World intellectual property organization publishes patent of amgen, kevin j. Hamblett , john stephen hill for "methods of treating epidermal growth factor deletion mutant viii related disorders" (american inventors) geneva , 2013-05-24 -- Publication no. Wo/2013/075048 was published on may 23 . Title of the invention: "methods of treating epidermal growth factor deletion mutant viii related disorders." applicants: Amgen...

  • Industries : Biopharmaceutical
  • Countries : United States
Genomics Innovation Trends in The United States: U.S. Patent granted to Callida Genomics on 2013-05-21 for

Genomics Innovation Trends In The United States: U.s. Patent Granted To Callida Genomics On 2013-05-21 For "single Molecule Arrays For Genetic And Chemical Analysis" (california Inventors)

  • Company news
  • 2 days ago
  • by HT Media

ALEXANDRIA, Va. , 2013-05-24 -- United States Patent no. 8,445,196, issued on May 21 , was assigned to Callida Genomics incorporated ( Sunnyvale, Calif. ). "Single molecule arrays for genetic , chemical analysis" was invented by Radoje T. Drmanac ( Los Altos Hills, Calif. ), Matthew J. Callow ( Redwood City, Calif. ), Snezana Drmanac ( Los Altos Hills, Calif. ), Brian K. Hauser ( Campbell...

  • Industries : Genomics
  • Countries : United States

Reportlinker.com © Copyright 2013. All rights reserved.

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.